Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03611972 · ClinicalTrials.gov registry record · NA
Sucrose-sweetened Beverage in African-American and Caucasian Women.
A NA study, sponsored by University of California, Davis.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03611972: Clinical Trial NA study, sponsored by University of California, Davis.
NCT03611972 is a NA study that was terminated before completion, run by University of California, Davis. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03611972, a NA study, was terminated before completion, sponsored by University of California, Davis.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The main objective of this pilot study is to measure changes in metabolic risk factors of cardiovascular disease and type 2 diabetes in response to sugar-sweetened beverages in African-American and non-Hispanic white women.
Primary Outcome
Fasting and postprandial plasma triglycerides
Interventions
- DIETARY_SUPPLEMENT Sugar-sweetened beverage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2018-08-20 |
| Est. Completion | 2022-03-30 |
| Phase | NA |
Why NCT03611972 stopped before completion
NCT03611972 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Sugar-sweetened beverage is the first listed.
NCT03611972 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03611972 about?
NCT03611972 is a clinical study titled "Sucrose-sweetened Beverage in African-American and Caucasian Women.". The main objective of this pilot study is to measure changes in metabolic risk factors of cardiovascular disease and type 2 diabetes in response to sugar-sweetened beverages in African-American and non-Hispanic white women.
What is the current status of trial NCT03611972?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2018-08-20. Estimated completion is 2022-03-30.
What interventions are being tested in trial NCT03611972?
The interventions under investigation include: Sugar-sweetened beverage (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03611972?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03611972's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI